Sad that anybody takes Mayo seriously or God-forbid buys the stock on his recommendation. He’s a self-proclaimed biotech “analyst” with no medical or healthcare background whatsoever (though he’s good at building a nifty little website and getting himself onto the quarterly calls). I’ve been investing in biotech since before he was born and so have many here, so I guess any of us here could also call ourselves biotech analysts. If Mayo is a biotech analyst then I might as well declare myself a defense intelligence analyst since I read newspaper articles on the subject and lived through the Cold War.
Market Data 
Markets 
